Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
Lu-Lu Zhai,1,2,* Yang Wu,1,2,* Chong-Yang Cai,1,2 Zhi-Gang Tang1,2 1Department of General Surgery, Affiliated Provincial Hospital, Anhui Medical University, 2Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, People’s Republic of China *These authors contributed equa...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/upregulated-matrix-metalloproteinase-2-and-downregulated-tissue-factor-peer-reviewed-article-OTT |
id |
doaj-fb12dba282d24864957d31b772ba68bb |
---|---|
record_format |
Article |
spelling |
doaj-fb12dba282d24864957d31b772ba68bb2020-11-25T01:36:45ZengDove Medical PressOncoTargets and Therapy1178-69302015-10-012015default2827283424036Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinomaZhai LLWu YCai CYTang ZGLu-Lu Zhai,1,2,* Yang Wu,1,2,* Chong-Yang Cai,1,2 Zhi-Gang Tang1,2 1Department of General Surgery, Affiliated Provincial Hospital, Anhui Medical University, 2Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, People’s Republic of China *These authors contributed equally to this work Background: Dysregulated expression of matrix metalloproteinase (MMP)-2 and tissue factor pathway inhibitor (TFPI)-2 is closely associated with tumorigenesis and tumor progression. The aim of this work was to determine the predictive values of MMP-2 and TFPI-2 in identifying lymph node metastasis (LNM) and perineural invasion (PNI) in pancreatic carcinoma.Methods: Formalin-fixed and paraffin-embedded tissue samples containing pancreatic carcinoma tissues and their corresponding para-carcinoma tissues were obtained from 122 patients with pancreatic carcinoma. The expression levels of MMP-2 and TFPI-2 were evaluated by immunohistochemistry. The roles of MMP-2 and TFPI-2 in predicting LNM and PNI in pancreatic carcinoma were analyzed.Results: The level of MMP-2 expression was markedly increased in pancreatic carcinoma tissues (76.9%) compared with para-carcinoma tissues (29.2%; P<0.05). In contrast, there was obviously decreased TFPI-2 expression level in pancreatic carcinoma tissues (29.2%) compared with para-carcinoma tissues (77.7%; P<0.001). Additionally, MMP-2 expression was significantly positively correlated with LNM (r=0.468, P<0.01) and PNI (r=0.637, P<0.01). In contrast, TFPI-2 expression was strongly negatively correlated with LNM (r=-0.396, P<0.001) and PNI (r=-0.460, P<0.001). Logistic regression analysis showed that high MMP-2 expression and low TFPI-2 expression acted as independent predictors for LNM and PNI in pancreatic carcinoma.Conclusion: Taken together, our findings suggest that upregulated MMP-2 and downregulated TFPI-2 serve as useful predictors for a high risk of LNM and PNI. Obtaining information on the expression of MMP-2 and TFPI-2 before surgery may predict the occurrence of LNM and PNI, thereby permitting reasonable and effective surgical treatment for patients with pancreatic carcinoma. Keywords: MMP-2, TFPI-2, immunohistochemistryhttps://www.dovepress.com/upregulated-matrix-metalloproteinase-2-and-downregulated-tissue-factor-peer-reviewed-article-OTT |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhai LL Wu Y Cai CY Tang ZG |
spellingShingle |
Zhai LL Wu Y Cai CY Tang ZG Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma OncoTargets and Therapy |
author_facet |
Zhai LL Wu Y Cai CY Tang ZG |
author_sort |
Zhai LL |
title |
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma |
title_short |
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma |
title_full |
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma |
title_fullStr |
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma |
title_full_unstemmed |
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma |
title_sort |
upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma |
publisher |
Dove Medical Press |
series |
OncoTargets and Therapy |
issn |
1178-6930 |
publishDate |
2015-10-01 |
description |
Lu-Lu Zhai,1,2,* Yang Wu,1,2,* Chong-Yang Cai,1,2 Zhi-Gang Tang1,2 1Department of General Surgery, Affiliated Provincial Hospital, Anhui Medical University, 2Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, People’s Republic of China *These authors contributed equally to this work Background: Dysregulated expression of matrix metalloproteinase (MMP)-2 and tissue factor pathway inhibitor (TFPI)-2 is closely associated with tumorigenesis and tumor progression. The aim of this work was to determine the predictive values of MMP-2 and TFPI-2 in identifying lymph node metastasis (LNM) and perineural invasion (PNI) in pancreatic carcinoma.Methods: Formalin-fixed and paraffin-embedded tissue samples containing pancreatic carcinoma tissues and their corresponding para-carcinoma tissues were obtained from 122 patients with pancreatic carcinoma. The expression levels of MMP-2 and TFPI-2 were evaluated by immunohistochemistry. The roles of MMP-2 and TFPI-2 in predicting LNM and PNI in pancreatic carcinoma were analyzed.Results: The level of MMP-2 expression was markedly increased in pancreatic carcinoma tissues (76.9%) compared with para-carcinoma tissues (29.2%; P<0.05). In contrast, there was obviously decreased TFPI-2 expression level in pancreatic carcinoma tissues (29.2%) compared with para-carcinoma tissues (77.7%; P<0.001). Additionally, MMP-2 expression was significantly positively correlated with LNM (r=0.468, P<0.01) and PNI (r=0.637, P<0.01). In contrast, TFPI-2 expression was strongly negatively correlated with LNM (r=-0.396, P<0.001) and PNI (r=-0.460, P<0.001). Logistic regression analysis showed that high MMP-2 expression and low TFPI-2 expression acted as independent predictors for LNM and PNI in pancreatic carcinoma.Conclusion: Taken together, our findings suggest that upregulated MMP-2 and downregulated TFPI-2 serve as useful predictors for a high risk of LNM and PNI. Obtaining information on the expression of MMP-2 and TFPI-2 before surgery may predict the occurrence of LNM and PNI, thereby permitting reasonable and effective surgical treatment for patients with pancreatic carcinoma. Keywords: MMP-2, TFPI-2, immunohistochemistry |
url |
https://www.dovepress.com/upregulated-matrix-metalloproteinase-2-and-downregulated-tissue-factor-peer-reviewed-article-OTT |
work_keys_str_mv |
AT zhaill upregulatedmatrixmetalloproteinase2anddownregulatedtissuefactorpathwayinhibitor2areriskfactorsforlymphnodemetastasisandperineuralinvasioninpancreaticcarcinoma AT wuy upregulatedmatrixmetalloproteinase2anddownregulatedtissuefactorpathwayinhibitor2areriskfactorsforlymphnodemetastasisandperineuralinvasioninpancreaticcarcinoma AT caicy upregulatedmatrixmetalloproteinase2anddownregulatedtissuefactorpathwayinhibitor2areriskfactorsforlymphnodemetastasisandperineuralinvasioninpancreaticcarcinoma AT tangzg upregulatedmatrixmetalloproteinase2anddownregulatedtissuefactorpathwayinhibitor2areriskfactorsforlymphnodemetastasisandperineuralinvasioninpancreaticcarcinoma |
_version_ |
1725061161105227776 |